San Diego, CA, United States of America

Adventrx Pharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 4

% Expired Patents = 75.0

Forward Citations = 19

Loading Chart...
Loading Chart...

1 inventor (with patents filed for the assignee):

goldMedal Andrew Xian Chen (4 out of 37 patents)


4 patents:

Company Overview
Adventrx Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of proprietary product candidates for the treatment of cancer and infectious diseases. The company's lead product candidate is Ethyol, a cytoprotective agent used in cancer therapy to reduce the incidence of chemotherapy-induced side effects. Adventrx is dedicated to improving patient outcomes and quality of life through innovative drug development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

4 Patents

#1,009 in San Diego, CA

#14,086 in California

#60,778 in US

San Diego, CA (US)
San Diego, CA, United States of America
Forward Citations = 19

1 inventor:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Adventrx Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/adventrx-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…